Hydrogen Therapy Shows Promise for Muscle Loss in COPD Patients
Current evidence and emerging therapeutic strategies for non-exercise interventions in sarcopenia associated with chronic obstructive pulmonary disease: a narrative review
Research hubs: Respiratory System · Musculoskeletal System
- Authors
- Renjun Huang, Ligong Chen, Fang Tian, Yuanfang Xie, Yuexin Zhang, Fanjie Lin, Zili Zhang, Wenju Lu
- Journal
- Journal of Thoracic Disease
- Year
- 2026
- DOI
- 10.21037/jtd-2026-1097
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Chronic Obstructive Pulmonary Disease (COPD)
- Body System
- Respiratory
TL;DR
People with lung disease (COPD) often lose dangerous amounts of muscle, but exercise isn't always possible for the sickest patients — so scientists are testing other treatments like special proteins, vitamins, and even hydrogen therapy to help rebuild muscle strength. This review rounds up the best options we have so far and points toward exciting new treatments on the horizon.
Key Finding
Hydrogen therapy was identified as a preclinical-stage intervention that may reduce muscle wasting in COPD through antioxidant and anti-inflammatory effects, but no human trial data in COPD patients currently exists.
Summary
This review article examined non-exercise treatments for muscle loss (sarcopenia) in people with chronic obstructive pulmonary disease (COPD), a lung condition that makes breathing difficult. The authors searched published research and organized treatments into three tiers based on how much evidence exists. Hydrogen therapy appeared in the second tier, meaning it has shown promise in animal or lab studies but has not yet been tested in clinical trials with COPD patients. The review concluded that several approaches, including hydrogen therapy, deserve further investigation.
Practical Takeaway
This is a review article, not a clinical trial, and hydrogen therapy's potential role in COPD-related muscle loss is based only on animal or lab studies so far. Early evidence suggests it may work through reducing inflammation and oxidative stress (cellular damage from unstable molecules), but it is too soon to draw conclusions about its usefulness for people with COPD. Human trials would be needed before any practical recommendations could be made.
Abstract (excerpt)
Background and objective: Skeletal muscle provides the foundation for respiration and physical activity and plays an essential role in human survival. Chronic obstructive pulmonary disease (COPD)-associated sarcopenia is highly prevalent and significantly affects exercise tolerance, quality…